3,3'-diethyl-2,2'-oxathiacarbocyanine iodide

Modify Date: 2024-01-07 19:05:49

3,3'-diethyl-2,2'-oxathiacarbocyanine iodide Structure
3,3'-diethyl-2,2'-oxathiacarbocyanine iodide structure
Common Name 3,3'-diethyl-2,2'-oxathiacarbocyanine iodide
CAS Number 15185-43-0 Molecular Weight 512.38300
Density N/A Boiling Point N/A
Molecular Formula C25H25IN2O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name 3,3'-diethyl-2,2'-oxathiacarbocyanine iodide
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C25H25IN2O2
Molecular Weight 512.38300
Exact Mass 512.09600
PSA 35.09000
LogP 2.19920

 MSDS

Name: 3 3 -Diethyloxatricarbocyanine Iodide Laser Grade 99% (UV-Vis) Material Safety Data Sheet
Synonym: None
CAS: 15185-43-0
Section 1 - Chemical Product MSDS Name:3 3 -Diethyloxatricarbocyanine Iodide Laser Grade 99% (UV-Vis) Material Safety Data Sheet
Synonym:None

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
15185-43-0 3,3'-Diethyloxatricarbocyanine Iodide 99 239-237-1
Hazard Symbols: XN
Risk Phrases: 20/21/22

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Chronic ingestion of iodides during pregnancy has resulted in fetal death, severe goiter, and cretinoid appearance of the newborn.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
Chronic ingestion of iodides during pregnancy has resulted in fetal death, severe goiter, and cretinoid appearance of the newborn..
Prolonged exposure to iodides may produce iodism in sensitive individuals. Symptoms could include skin rash, running nose and headache.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 15185-43-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C25H25IN2O2
Molecular Weight: 512.39

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide, oxides of iodine.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 15185-43-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3,3'-Diethyloxatricarbocyanine Iodide - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 15185-43-0: No information available.
Canada
CAS# 15185-43-0 is listed on Canada's NDSL List.
CAS# 15185-43-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 15185-43-0 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Hazard Codes Xn

 Synthetic Route

~%

3,3'-diethyl-2,2'-oxathiacarbocyanine iodide Structure

3,3'-diethyl-2,...

CAS#:15185-43-0

Literature: Eastman Kodak Co. Patent: US2251286 , 1937 ;

 Synonyms

3,3'-DIETHYL-2,2'-OXATRICARBOCYANINE IODIDE
lasergrade
3,3'-Diethyloxatricarbocyanin-jodid
3,3'-DIETHYLOXATRICARBOCYANINE IODIDE,F OR FLUORESCENCE
3-ethyl-2-[7-(3-ethyl-3H-benzoxazol-2-ylidene)hepta-1,3,5-trienyl]benzoxazolium iodide
3,3'-Diethyloxatricarbocyanine iodideDOTC iodide
DOTC IODIDE
DOTCL
1,7-Bis-(3-aethyl-benzoxazol-2-yl)-heptamethinium,Jodid
1,7-bis-(3-ethyl-benzoxazol-2-yl)-heptamethinium,iodide
dotci
diethyloxatricarbocyanine iodide
3,3'-DIETHYLOXATRICARBOCYANINE IODIDE
Related Compounds: More...
3,3'-DIETHYL-2,2'-THIADICARBOCYANINE PERCHLORATE
22268-65-1
5,6-dimethyl-2-(3-(5,6-dimethyl-3-ethyl-2-benzoxazolinylidene)-1-propenyl)-3-ethyl benzoxazolium iodide
52078-66-7
3-ethyl-2-[3-(3-ethyl-3H-benzoselenazol-2-ylidene)prop-1-enyl]benzoxazolium iodide
32835-25-9
bis<3-ethyl-5-rhodanine>methinecyanine
40485-72-1
[5,5'-Bithiazolidine]-4,4'-dione,3,3'-diethyl-2,2'-dithioxo-
41270-44-4
5,5'-bis(benzyloxycarbonyl-4,4'-dimethyl-3,3'-diethyl-2,2'-dipyrrolyl)methane
7670-40-8
(5,5'-bis(methoxymethyl)-4,4'-dimethyl-3,3'-diethyl-2,2'-dipyrryl)methene hydrobromide
87597-44-2
3-ethyl-2-[(3-ethyl-4-methyl-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrole
92415-30-0
4-Thiazolidinone,3-ethyl-5-(3-ethyl-4-oxo-2-thioxo-5-thiazolidinylidene)-2-thioxo- (9CI)
6654-57-5
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
tert-Butyl-DL-alanine
1375289-11-4
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
2-Ethyl-6-(iodomethyl)-2-(trifluoromethyl)-1,4-dioxane
2172053-72-2